Benchmark Upgrades Repligen (RGEN) to Buy
Benchmark analyst Robert Wasserman upgraded Repligen (NASDAQ: RGEN) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
